Electrolyte abnormalities in chronic heart failure patients on treatment with two different drug regimens
Journal Title: Medpulse International Journal of Biochemistry - Year 2018, Vol 5, Issue 3
Abstract
Background: Heart failure is a complex clinical syndrome, impairing the ability of the cardiac ventricles to fill with or eject blood. Drug therapy for Chronic Heart Failure (CHF) is aimed at providing symptomatic relief and has to be continued indefinitely. Currently Angiotensin Converting Enzyme Inhibitor (ACEI), beta blocker and diuretic form the basis of treatment for CHF. These drugs can cause a wide array of electrolyte disturbances which frequently result in potentially dangerous complications. Early identification of these electrolyte disturbances and knowledge of the pathophysiological mechanisms underlying them will help in the effective management of these patients, when complex combinations of drugs are used. Objectives: 1.To estimate the serum sodium and potassium levels in ‘stable’ Chronic Heart Failure (CHF) patients on treatment. 2. To study the impact of Angiotensin Converting Enzyme inhibitors (ACEI), beta blockers and spironolactone with or without furosemide on serum sodium and potassium levels in stable CHF patients receiving the above drugs. Materials and Methods: A cross-sectional study was conducted on 120 stable chronic heart failure patients. In this, 60 patients were under Angiotensin Converting Enzyme inhibitors(ACEI), beta blockers, spironolactone and furosemide, while the other 60 patients were under Angiotensin Converting Enzyme inhibitors(ACEI), beta blockers and spironolactone regimen. Serum creatinine, sodium and potassium levels were analyzed in both the group. Conclusion: Majority of the drugs used in the treatment of CHF cause electrolyte disturbances. Hyponatremia in patients receiving all the four drugs and hyperkalemia in patients receiving only three drugs, was observed in our study.
Authors and Affiliations
A Khadeja Bi, S Suganya, Jnankumar Chaudhuri
Keywords
Related Articles
- EP ID EP486163
- DOI 10.26611/10025310
- Views 190
- Downloads 0
Role of 25 hydroxy Vitamin-D in parkinson’s disease
Abstract Problem statement: Parkinson disease is the second most prevalent neurodegenerative disease worldwide. In the initial stage of the disease, the most obvious symptoms are movement related, which include tremors,...
Study of serum Malondialdehyde, nitric oxide and vitamin E in rheumatoid arthritis patients before and after the supplementation of vitamin E
Background: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disorder that may affect many tissues and organs – skin, blood vessels, heart, lungs and muscles but principally attacks the joints, producing a no...
A study of serum Cystatin C levels in type 2 diabetes mellitus patients with normoalbuminuria, microalbuminuria and macroalbuminuria
Background: Diabetic nephropathy, a major microvascular complication of diabetes mellitus, is a leading cause of end-stage renal disease. Early detection of renal dysfunction is the only way to avoid the morbidity and mo...
Ischaemia modified albumin levels in hyperthyroidism
Background: Hyperthyroidism is characterised by increased levels of thyroid hormones leading to hypermetabolic state. More common in females than males with sex ratio of up to 5:1. Thyroid hormone functions as a stimulus...
Study of effects of Epigallocatectin-gallate (EGCG) on lipid profile and thereby cardiovascular risk
Background: Nowadays use of green tea has been increasing worldwide due to the beneficial effects it has on cardiovascular system. The beneficial effects of green tea can be attributed to the presence of various catectin...